BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Barbara E. Souza

Barbara E. Souza contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
cond-mat.mtrl-sci

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2021arXiv

Green reconstruction of MIL-100 (Fe) in water for high crystallinity and enhanced guest encapsulation

MIL-100 (Fe) is a highly porous metal-organic framework (MOF), considered as a promising carrier for drug delivery, and for gas separation and capture applications. However, this functional material suffers from elaborated and toxic synthesis that may hinder its biomedical use and large-scale production to afford commercial applications. Herein, we report a green mechanochemical water immersion approach to yield highly crystalline MIL100 (Fe) material. Subsequently, we have harnessed this strategy for facile fabrication of drug@MOF composite systems, comprising (guests) 5-fluorouracil, caffeine, or aspirin encapsulated in the pores of (host) MIL-100 (Fe). Inelastic neutron scattering was uniquely used to probe the guest host interactions arising from pore confinement of the drug molecules, giving additional insights into the reconstruction mechanism. Our results pave the way to the green production of MIL type materials and bespoke guest-encapsulated composites by minimizing the use of toxic chemicals, whilst enhancing energy efficiency and material's life cycle central to biotechnological applications.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Highly luminescent silver-based MOFs: Scalable eco-friendly synthesis paving the way for photonics sensors and electroluminescent devices

Luminescent multifunctional nanomaterials are important because of their potential impact on the development of key technologies such as smart luminescent sensors and solid-state lightings. To be technologically viable, the luminescent material needs to fulfil a number of requirements such as facile and cost-effective fabrication, a high quantum yield, structural robustness, and long-term material stability. To achieve these requirements, an eco-friendly and scalable synthesis of a highly photoluminescent, multistimuli responsive and electroluminescent silver-based metal-organic framework (Ag-MOF), termed "OX-2" was developed. Its exceptional photophysical and mechanically resilient properties that can be reversibly switched by temperature and pressure make this material stood out over other competing luminescent materials. The potential use of OX-2 MOF as a good electroluminescent material was tested by constructing a proof-of-concept MOF-LED (light emitting diode) device, further contributing to the rare examples of electroluminescent MOFs. The results reveal the huge potential for exploiting the Ag MOF as a multitasking platform to engineer innovative photonic technologies.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics

Novel MOF-based polymer nanocomposite films were successfully prepared using Zr-based UiO-67 as a metal-organic framework (MOF) and polyurethane (PU) as a polymeric matrix. Synchrotron X-ray powder diffraction (SXRPD) analysis confirms the improved stability of the UiO-67 embedded nanocrystals and scanning electron microscopy images confirm their homogeneous distribution (average crystal size ~100-200 nm) within the 50-um thick film. Accessibility to the inner porous structure of the embedded MOFs was completely suppressed for N2 at cryogenic temperatures. However, ethylene adsorption measurements at 25°C confirm that at least 45% of the MOF crystals are fully accessible for gas phase adsorption of non-polar molecules. Although this partial blockage limits the adsorption performance of the embedded MOFs for ocular drugs (e.g., brimonidine tartrate) compared to the pure MOF, an almost 60-fold improvement in the adsorption capacity was observed for PU matrix after incorporation of the UiO-67 nanocrystals. UiO-67@PU nanocomposite exhibits a prolonged release of brimonidine (up to 14 days were quantified). Finally, the combined use of SXRPD, thermogravimetric analysis (TGA) and FTIR analysis confirmed the presence of the drug in the nanocomposite film, the stability of the MOF framework and the drug upon loading, and the presence of brimonidine in an amorphous phase once adsorbed. These results open the gate towards the application of these polymeric nanocomposite films for drug delivery in optical therapeutics, either as a component of contact lens, in the composition of lacrimal stoppers (e.g., punctal plugs) or in sub-tenon inserts.

0 citations0 reviewsNo code linkedOpen access